Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135694518> ?p ?o ?g. }
- W2135694518 endingPage "731" @default.
- W2135694518 startingPage "723" @default.
- W2135694518 abstract "Epstein-Barr virus (EBV) primary infection constitutes a serious risk for pediatric transplant recipients, particularly as regards the development of EBV-related post-transplant lymphoproliferative disease (PTLD). Currently, there is no established prophylactic regimen. We investigated the association between chemoprophylaxis with valganciclovir (VGCV) or ganciclovir (GCV) and the incidence of EBV viremia in EBV-naïve pediatric renal transplant recipients (R-) who had received a graft from an EBV-positive donor (D+) and are therefore at high risk of EBV primary infection. In a prospective, multicenter trial (n = 114), we compared a cohort on chemoprophylaxis (n = 20) with a similar control cohort without chemoprophylaxis (n = 8). Over the 1-year study period, antiviral prophylaxis with VGCV/GCV was associated with a significantly decreased incidence of EBV primary infection: 9/20 patients (45%) in the prophylaxis group experienced an EBV primary infection compared to 8/8 controls (100%) (P < 0.0001). Chemoprophylaxis was associated with a significantly lower EBV viral load (P < 0.001). Type or intensity of immunosuppressive therapy did not influence the occurrence of EBV primary infection or the level/persistence of EBV viral load. Chemoprophylaxis with VGCV/GCV is associated with a reduced incidence of EBV viremia in high-risk pediatric kidney allograft recipients in the first year post-transplant. (ClinicalTrials.gov number: NCT00963248)." @default.
- W2135694518 created "2016-06-24" @default.
- W2135694518 creator A5006919482 @default.
- W2135694518 creator A5012451636 @default.
- W2135694518 creator A5015282079 @default.
- W2135694518 creator A5017420290 @default.
- W2135694518 creator A5017660773 @default.
- W2135694518 creator A5019792676 @default.
- W2135694518 creator A5020051678 @default.
- W2135694518 creator A5025101197 @default.
- W2135694518 creator A5026976492 @default.
- W2135694518 creator A5040618608 @default.
- W2135694518 creator A5044136682 @default.
- W2135694518 creator A5048588130 @default.
- W2135694518 creator A5053089611 @default.
- W2135694518 creator A5075336914 @default.
- W2135694518 creator A5090990638 @default.
- W2135694518 date "2012-04-25" @default.
- W2135694518 modified "2023-10-10" @default.
- W2135694518 title "(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation" @default.
- W2135694518 cites W1555918218 @default.
- W2135694518 cites W1968496091 @default.
- W2135694518 cites W1977920864 @default.
- W2135694518 cites W1992805816 @default.
- W2135694518 cites W1994080024 @default.
- W2135694518 cites W2003303285 @default.
- W2135694518 cites W2008730109 @default.
- W2135694518 cites W2036464481 @default.
- W2135694518 cites W2062036448 @default.
- W2135694518 cites W2063622588 @default.
- W2135694518 cites W2087762810 @default.
- W2135694518 cites W2103598992 @default.
- W2135694518 cites W2116508491 @default.
- W2135694518 cites W2119441823 @default.
- W2135694518 cites W2134568690 @default.
- W2135694518 cites W2134956041 @default.
- W2135694518 cites W2139033805 @default.
- W2135694518 cites W2144590996 @default.
- W2135694518 cites W2148338320 @default.
- W2135694518 cites W2159455867 @default.
- W2135694518 cites W2160479322 @default.
- W2135694518 cites W2163247444 @default.
- W2135694518 cites W2324553589 @default.
- W2135694518 cites W2522939951 @default.
- W2135694518 cites W4211083670 @default.
- W2135694518 doi "https://doi.org/10.1111/j.1432-2277.2012.01485.x" @default.
- W2135694518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22533698" @default.
- W2135694518 hasPublicationYear "2012" @default.
- W2135694518 type Work @default.
- W2135694518 sameAs 2135694518 @default.
- W2135694518 citedByCount "79" @default.
- W2135694518 countsByYear W21356945182012 @default.
- W2135694518 countsByYear W21356945182013 @default.
- W2135694518 countsByYear W21356945182014 @default.
- W2135694518 countsByYear W21356945182015 @default.
- W2135694518 countsByYear W21356945182016 @default.
- W2135694518 countsByYear W21356945182017 @default.
- W2135694518 countsByYear W21356945182018 @default.
- W2135694518 countsByYear W21356945182019 @default.
- W2135694518 countsByYear W21356945182020 @default.
- W2135694518 countsByYear W21356945182021 @default.
- W2135694518 countsByYear W21356945182022 @default.
- W2135694518 countsByYear W21356945182023 @default.
- W2135694518 crossrefType "journal-article" @default.
- W2135694518 hasAuthorship W2135694518A5006919482 @default.
- W2135694518 hasAuthorship W2135694518A5012451636 @default.
- W2135694518 hasAuthorship W2135694518A5015282079 @default.
- W2135694518 hasAuthorship W2135694518A5017420290 @default.
- W2135694518 hasAuthorship W2135694518A5017660773 @default.
- W2135694518 hasAuthorship W2135694518A5019792676 @default.
- W2135694518 hasAuthorship W2135694518A5020051678 @default.
- W2135694518 hasAuthorship W2135694518A5025101197 @default.
- W2135694518 hasAuthorship W2135694518A5026976492 @default.
- W2135694518 hasAuthorship W2135694518A5040618608 @default.
- W2135694518 hasAuthorship W2135694518A5044136682 @default.
- W2135694518 hasAuthorship W2135694518A5048588130 @default.
- W2135694518 hasAuthorship W2135694518A5053089611 @default.
- W2135694518 hasAuthorship W2135694518A5075336914 @default.
- W2135694518 hasAuthorship W2135694518A5090990638 @default.
- W2135694518 hasBestOaLocation W21356945181 @default.
- W2135694518 hasConcept C120665830 @default.
- W2135694518 hasConcept C121332964 @default.
- W2135694518 hasConcept C126322002 @default.
- W2135694518 hasConcept C142462285 @default.
- W2135694518 hasConcept C203014093 @default.
- W2135694518 hasConcept C2522874641 @default.
- W2135694518 hasConcept C2776185481 @default.
- W2135694518 hasConcept C2776317777 @default.
- W2135694518 hasConcept C2776688490 @default.
- W2135694518 hasConcept C2777965375 @default.
- W2135694518 hasConcept C2779820661 @default.
- W2135694518 hasConcept C2911091166 @default.
- W2135694518 hasConcept C61511704 @default.
- W2135694518 hasConcept C71924100 @default.
- W2135694518 hasConcept C90924648 @default.
- W2135694518 hasConceptScore W2135694518C120665830 @default.
- W2135694518 hasConceptScore W2135694518C121332964 @default.
- W2135694518 hasConceptScore W2135694518C126322002 @default.